![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 45/06 | (2006.01) |
C07C 309/19 | (2006.01) | ||
C07D 487/06 | (2006.01) | ||
C07C 57/145 | (2006.01) | ||
A61K 31/55 | (2006.01) |
(11) | Number of the document | 2534153 |
(13) | Kind of document | T |
(96) | European patent application number | 11708094.5 |
Date of filing the European patent application | 2011-02-10 | |
(97) | Date of publication of the European application | 2012-12-19 |
(45) | Date of publication and mention of the grant of the patent | 2016-09-21 |
(46) | Date of publication of the claims translation | 2016-12-12 |
(86) | Number | PCT/IB2011/050571 |
Date | 2011-02-10 |
(87) | Number | WO 2011/098971 |
Date | 2011-08-18 |
(30) | Number | Date | Country code |
304277 P | 2010-02-12 | US |
(72) |
BASFORD, Patricia, Ann, GB
CAMPETA, Anthony, Michael, US
GILLMORE, Adam, GB
JONES, Matthew, Cameron, GB
KOUGOULOS, Eleftherios, US
LUTHRA, Suman, US
WALTON, Robert, GB
|
(73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 8-Fluor-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6H-azepino[5,4,3-CD]indol-6-ono druskos ir polimorfai |
SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE |
Payment date | Validity (years) | Amount | |
2025-01-23 | 15 | 289.00 EUR |
2026-02-10 |